minimally invasive glaucoma surgery (migs) devices market

Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026

  • Published Date: 2021-01-17
  • Report ID: 38672
  • Pages: 103
  • Format: prudent report format

Summary

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Minimally Invasive Glaucoma Surgery (MIGS) Devices market in this environment.

In terms of revenue, this research report indicated that the global Minimally Invasive Glaucoma Surgery (MIGS) Devices market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Minimally Invasive Glaucoma Surgery (MIGS) Devices industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The Ellex Medical Lasers Ltd aims at producing XX Minimally Invasive Glaucoma Surgery (MIGS) Devices in 2020, with XX % production to take place in global market, Allergan Plc accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
Ellex Medical Lasers Ltd
Allergan Plc
Santen Pharmaceutical Co., Ltd.
Glaukos Corporation
Alcon Inc. (Novartis)
Lumenis
Ivantis
iSTAR Medical
InnFocus
SOLX
...
Major Type of Minimally Invasive Glaucoma Surgery (MIGS) Devices Covered in Prudent Markets report:
Glaucoma in Conjunction with Cataract
Stand Alone Glaucoma
Application Segments Covered in Prudent Markets Market
Eye Hospitals
Ophthalmology Clinics
Outpatient Surgical Centers

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Glaucoma in Conjunction with Cataract -Product Introduction and Major Manufacturers
1.1.2 Stand Alone Glaucoma -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
3.1.1 Top Companies leading Minimally Invasive Glaucoma Surgery (MIGS) Devices Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Minimally Invasive Glaucoma Surgery (MIGS) Devices Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
3.2.1 Top Companies leading Minimally Invasive Glaucoma Surgery (MIGS) Devices Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Minimally Invasive Glaucoma Surgery (MIGS) Devices Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
3.3.1 Top Companies leading Minimally Invasive Glaucoma Surgery (MIGS) Devices Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
3.4.1 Top Companies leading Minimally Invasive Glaucoma Surgery (MIGS) Devices Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
3.5.1 Top Companies leading Minimally Invasive Glaucoma Surgery (MIGS) Devices Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Minimally Invasive Glaucoma Surgery (MIGS) Devices Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
3.6.1 Top Companies leading Minimally Invasive Glaucoma Surgery (MIGS) Devices Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Minimally Invasive Glaucoma Surgery (MIGS) Devices Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
3.7.1 Top Companies leading Minimally Invasive Glaucoma Surgery (MIGS) Devices Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Minimally Invasive Glaucoma Surgery (MIGS) Devices Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Minimally Invasive Glaucoma Surgery (MIGS) Devices Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales and Growth Rate (2021-2026)
5.2 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Sales Value and Growth Rate (2021-2026)

6 Minimally Invasive Glaucoma Surgery (MIGS) Devices Competitive Analysis
6.1 Ellex Medical Lasers Ltd
6.1.1 Ellex Medical Lasers Ltd Company Profiles
6.1.2 Ellex Medical Lasers Ltd Product Introduction
6.1.3 Ellex Medical Lasers Ltd Minimally Invasive Glaucoma Surgery (MIGS) Devices Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Allergan Plc
6.2.1 Allergan Plc Company Profiles
6.2.2 Allergan Plc Product Introduction
6.2.3 Allergan Plc Minimally Invasive Glaucoma Surgery (MIGS) Devices Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Santen Pharmaceutical Co., Ltd.
6.3.1 Santen Pharmaceutical Co., Ltd. Company Profiles
6.3.2 Santen Pharmaceutical Co., Ltd. Product Introduction
6.3.3 Santen Pharmaceutical Co., Ltd. Minimally Invasive Glaucoma Surgery (MIGS) Devices Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Glaukos Corporation
6.4.1 Glaukos Corporation Company Profiles
6.4.2 Glaukos Corporation Product Introduction
6.4.3 Glaukos Corporation Minimally Invasive Glaucoma Surgery (MIGS) Devices Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Alcon Inc. (Novartis)
6.5.1 Alcon Inc. (Novartis) Company Profiles
6.5.2 Alcon Inc. (Novartis) Product Introduction
6.5.3 Alcon Inc. (Novartis) Minimally Invasive Glaucoma Surgery (MIGS) Devices Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Lumenis
6.6.1 Lumenis Company Profiles
6.6.2 Lumenis Product Introduction
6.6.3 Lumenis Minimally Invasive Glaucoma Surgery (MIGS) Devices Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Ivantis
6.7.1 Ivantis Company Profiles
6.7.2 Ivantis Product Introduction
6.7.3 Ivantis Minimally Invasive Glaucoma Surgery (MIGS) Devices Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 iSTAR Medical
6.8.1 iSTAR Medical Company Profiles
6.8.2 iSTAR Medical Product Introduction
6.8.3 iSTAR Medical Minimally Invasive Glaucoma Surgery (MIGS) Devices Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 InnFocus
6.9.1 InnFocus Company Profiles
6.9.2 InnFocus Product Introduction
6.9.3 InnFocus Minimally Invasive Glaucoma Surgery (MIGS) Devices Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
6.10 SOLX
6.10.1 SOLX Company Profiles
6.10.2 SOLX Product Introduction
6.10.3 SOLX Minimally Invasive Glaucoma Surgery (MIGS) Devices Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
7 Conclusion


CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.